These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9266991)

  • 21. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus.
    Wrona T; Dudley JP
    J Virol; 1996 Feb; 70(2):1246-9. PubMed ID: 8551589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gradual elimination of retroviruses in YBR/Ei mice.
    MacDearmid CC; Case LK; Starling CL; Golovkina TV
    J Virol; 2006 Mar; 80(5):2206-15. PubMed ID: 16474128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
    J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
    Schochetman G; Arthur LO; Long CW; Massey RJ
    J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.
    Ardavin C; Luthi F; Andersson M; Scarpellino L; Martin P; Diggelmann H; Acha-Orbea H
    J Virol; 1997 Oct; 71(10):7295-9. PubMed ID: 9311805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
    Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mechanism of resistance to mouse mammary tumor virus infection.
    Golovkina TV
    J Virol; 2000 Mar; 74(6):2752-9. PubMed ID: 10684291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse mammary tumor viruses expressed by RIII/Sa mice with a high incidence of mammary tumors interact with the V beta-2- and V beta-8-specific T cells during viral infection.
    Uz-Zaman T; Ignatowicz L; Sarkar NH
    Virology; 2003 Sep; 314(1):294-304. PubMed ID: 14517082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.
    Vacheron S; Renno T; Acha-Orbea H
    J Virol; 1997 Oct; 71(10):7289-94. PubMed ID: 9311804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus.
    Ando Y; Wajjwalku W; Kishihara K; Arai T; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    Immunobiology; 1996 Aug; 195(3):376-84. PubMed ID: 8877410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Superantigens and retroviral infections. Increase of mammary tumorigenicity due to recombination between exogenous and endogenous MMTV viruses].
    Nepomnaschy I; Buggiano V; Goldman A; Deroche A; Bekinschtein P; Berguer P; Piazzon I
    Medicina (B Aires); 1997; 57(3):327-31. PubMed ID: 9640768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.
    Zhang G; Chen M; Graham D; Subsin B; McDougall C; Gilady S; Kneteman M; Law L; Swain M; Trauner M; Wrzesinski S; Flavell R; Wasilenko S; Mason A
    J Hepatol; 2011 Oct; 55(4):876-84. PubMed ID: 21334408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model.
    Karapetian O; Shakhov AN; Kraehenbuhl JP; Acha-Orbea H
    J Exp Med; 1994 Oct; 180(4):1511-6. PubMed ID: 7931081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
    Ross SR; Dzuris JL; Golovkina TV; Clemmons WC; van den Hoogen B
    Medicina (B Aires); 1997; 57 Suppl 2():34-42. PubMed ID: 9567342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.
    Golovkina TV; Chervonsky A; Dudley JP; Ross SR
    Cell; 1992 May; 69(4):637-45. PubMed ID: 1316806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.